The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Epidemiology of prostate cancer in Asian countries
Open accessAbstract
The incidence of prostate cancer has been increasing worldwide in recent years. The GLOBOCAN project showed that prostate cancer was the second most frequently diagnosed cancer and the fifth leading cause of cancer mortality among men worldwide in 2012. This trend has been growing even in Asian countries, where the incidence had previously been low. However, the accuracy of data about incidence and mortality as a result of prostate cancer in some Asian countries is limited. The cause of this increasing trend is multifactorial. One possible explanation is changes in lifestyles due to more Westernized diets. The incidence is also statistically biased by the wide implementation of early detection systems and the accuracy of national cancer registration systems, which are still immature in most Asian countries. Mortality rate decreases in Australia, New Zealand and Japan since the 1990s are possibly due to the improvements in treatment and/or early detection efforts employed. However, this rate is increasing in the majority of other Asian countries. Studies of latent and incidental prostate cancer provide less biased information. The prevalence of latent and incidental prostate cancer in contemporary Japan and Korea is similar to those in Western countries, suggesting the influence of lifestyle changes on carcinogenesis. Many studies reported evidence of both congenital and acquired risk factors for carcinogenesis of prostate cancer. Recent changes in the acquired risk factors might be associated with the increasing occurrence of prostate cancer in Asian countries. This trend could continue, especially in developing Asian countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
A haplotype map of the human genome
The International HapMap Consortium (2005) · Nature · doi:10.1038/nature04226 · Cited by 5,858
International Variation in Prostate Cancer Incidence and Mortality Rates
Center, M. M., Jemal, A., Lortet-Tieulent, J., Ward, E., Ferlay, J., Brawley, O., & Bray, F. (2012) · European Urology · doi:10.1016/j.eururo.2012.02.054 · Cited by 1,521
Tenets of PTEN Tumor Suppression
Salmena, L., Carracedo, A., & Pandolfi, P. P. (2008) · Cell · doi:10.1016/j.cell.2008.04.013 · Cited by 1,034
Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009
Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County
Shimizu, H., Ross, R., Bernstein, L., Yatani, R., Henderson, B., & Mack, T. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.210 · Cited by 890
Age standardization of rates: a new WHO standard (GPE discussion paper Series: No. 31)
Ahmad, O., Boschi-Pinto, C., López, A. D., Murray, C. O., Lozano, R., Inoue, M., & Ahmad, O. R. A. (2002) · Cited by 707
Whittemore, A. S., Kolonel, L. N., Wu, A. H., John, E. M., Gallagher, R. P., Howe, G. R., Burch, J. D., Hankin, J., Dreon, D. M., West, D. W., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.9.652 · Cited by 665
Recurrent gene fusions in prostate cancer
Kumar-Sinha, C., Tomlins, S. A., & Chinnaiyan, A. M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2402 · Cited by 664
Germline Mutations in HOXB13 and Prostate-Cancer Risk
Ewing, C. M., Ray, A. M., Lange, E. M., Zuhlke, K. A., Robbins, C. M., Tembe, W. D., Wiley, K. E., Isaacs, S. D., Johng, D., Wang, Y., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110000 · Cited by 658
Micha, R., Khatibzadeh, S., Shi, P., Fahimi, S., Lim, S., Andrews, K. G., Engell, R. E., Powles, J., Ezzati, M., Mozaffarian, D., et al. (2014) · BMJ · doi:10.1136/bmj.g2272 · Cited by 573
A candidate prostate cancer susceptibility gene at chromosome 17p
Tavtigian, S. V., Simard, J., Teng, D. H. F., Abtin, V., Baumgard, M., Beck, A., Camp, N. J., Carillo, A. R., Chen, Y., Dayananth, P., et al. (2001) · Nature Genetics · doi:10.1038/84808 · Cited by 557
Germline mutations in the ribonuclease L gene in families showing linkage with HPC1
Carpten, J., Nupponen, N., Isaacs, S., Sood, R., Robbins, C., Xu, J., Faruque, M., Moses, T., Ewing, C., Gillanders, E., et al. (2002) · Nature Genetics · doi:10.1038/ng823 · Cited by 525
A meta-analysis of diabetes mellitus and the risk of prostate cancer
Kasper, J. S., & Giovannucci, E. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0410 · Cited by 491
Hsing, A. (2006) · Frontiers in Bioscience · doi:10.2741/1891 · Cited by 447
Xu, J., Zheng, S. L., Komiya, A., Mychaleckyj, J. C., Isaacs, S. D., Hu, J. J., Sterling, D., Lange, E. M., Hawkins, G. A., Turner, A., et al. (2002) · Nature Genetics · doi:10.1038/ng994 · Cited by 392
Geographic pathology of latent prostatic carcinoma
Yatani, R., Chigusa, I., Akazaki, K., Stemmermann, G. N., Welsh, R. A., & Correa, P. (1982) · International Journal of Cancer · doi:10.1002/ijc.2910290602 · Cited by 325
Fatty fish consumption and risk of prostate cancer
Terry, P., Lichtenstein, P., Feychting, M., Ahlbom, A., & Wolk, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04889-3 · Cited by 284
Discacciati, A., Orsini, N., & Wolk, A. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr603 · Cited by 278
Magi‐Galluzzi, C., Tsusuki, T., Elson, P., Simmerman, K., LaFargue, C., Esgueva, R., Klein, E., Rubin, M. A., & Zhou, M. (2011) · The Prostate · doi:10.1002/pros.21265 · Cited by 275
Ito, K. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.42 · Cited by 267
COOK, L. S., GOLDOFT, M., SCHWARTZ, S. M., & WEISS, N. S. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)62086-x · Cited by 241
Case-Control Studies of Prostate Cancer in Blacks and Whites in Southern California
Ross, R. K., Shimizu, H., Paganini‐Hill, A., Honda, G. D., & Henderson, B. E. (1987) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/78.5.869 · Cited by 239
Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies
Bansal, D., Bhansali, A., Kapil, G., Undela, K., & Tiwari, P. (2013) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2012.40 · Cited by 206
Epidemiology of prostate cancer in the Asia-Pacific region
Baade, P. D., Youlden, D. R., Cramb, S. M., Dunn, J., & Gardiner, R. A. (2013) · Prostate International · doi:10.12954/pi.12014 · Cited by 182
Epidemiology of Prostate Cancer
Bashir, M. N. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.13.5137 · Cited by 168
Choi, E., Lee, S. E., Bui, N. C., Suh, M., Park, B., Jun, J. K., & Choi, K. S. (2017) · Epidemiology and Health · doi:10.4178/epih.e2017006 · Cited by 161
Mao, X., Yu, Y., Boyd, L. K., Ren, G., Lin, D., Chaplin, T., Kudahetti, S. C., Stankiewicz, E., Xue, L., Beltrán, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4074 · Cited by 157
Kakehi, Y., Sugimoto, M., & Taoka, R. (2017) · International Journal of Urology · doi:10.1111/iju.13380 · Cited by 141
Increasing colorectal cancer incidence rates in Japan
Yiu, H. Y., Whittemore, A. S., & Shibata, A. (2004) · International Journal of Cancer · doi:10.1002/ijc.20030 · Cited by 137
Hoffmann, T. J., Eeden, S. K. V. D., Sakoda, L. C., Jorgenson, E., Habel, L. A., Graff, R. E., Passarelli, M. N., Cario, C. L., Emami, N. C., Chao, C., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0315 · Cited by 135
Dietary Fat and Prostate Cancer
Fleshner, N. E., Bagnell, P. S., Klotz, L. H., & Venkateswaran, V. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000107838.33623.19 · Cited by 115
Tsilidis, K. K., Allen, N. E., Appleby, P. N., Rohrmann, S., Nöthlings, U., Arriola, L., Gunter, M. J., Chajès, V., Rinaldi, S., Romieu, I., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28989 · Cited by 112
Prostate cancer in East Asia: evolving trend over the last decade
Ye, D., Zhu, Y., Wang, H., & Qu, Y. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.132780 · Cited by 98
Miyagi, Y., Sasaki, T., Fujinami, K., Sano, J., Senga, Y., Miura, T., Kameda, Y., Sakuma, Y., Nakamura, Y., Harada, M., et al. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.149 · Cited by 96
A novel Germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men
Lin, X., Qu, L., Chen, Z., Xu, C., Ye, D., Shao, Q., Wang, X., Qi, J., Chen, Z., Zhou, F., et al. (2012) · The Prostate · doi:10.1002/pros.22552 · Cited by 83
Hardin, J., Cheng, I. C., & Witte, J. S. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2011.582224 · Cited by 77
Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence
Pierce, B. L. (2012) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.07.008 · Cited by 68
Diabetes Mellitus and Prostate Cancer Risk in Asian Countries: a Meta-analysis
Long, X.-J., Lin, S., Sun, Y., & Zheng, Z. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.8.4097 · Cited by 58
Mutations of PTEN/MMAC1 in primary prostate cancers from Chinese patients.
Dong, J., Li, C., Sipe, T. W., & Frierson, H. F. (2001) · PubMed · Cited by 47
Allott, E. H., Arab, L., Su, L. J., Farnan, L., Fontham, E. T. H., Mohler, J. L., Bensen, J. T., & Steck, S. E. (2016) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2016.39 · Cited by 47
Ren, G., Liu, X., Mao, X., Zhang, Y., Stankiewicz, E., Hylands, L., Song, R., Berney, D. M., Clark, J., Cooper, C., et al. (2012) · Genes Chromosomes and Cancer · doi:10.1002/gcc.21984 · Cited by 46
Umbas, R., Safriadi, F., Mochtar, C. A., Djatisoesanto, W., & Hamid, A. R. A. H. (2015) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyv066 · Cited by 38
Prostate Cancer Incidence in Turkey: An Epidemiological Study
Zorlu, F., Divrik, R. T., Eser, S., & Yörükoğlu, K. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.21.9125 · Cited by 36
Germline Variants of Prostate Cancer in Japanese Families
Hayano, T., Matsui, H., Nakaoka, H., Ohtake, N., Hosomichi, K., Suzuki, K., & Inoue, I. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164233 · Cited by 32
Furusato, B., van Leenders, G. J. L. H., Trapman, J., Kimura, T., Egawa, S., Takahashi, H., Furusato, M., Visakorpi, T., & Hano, H. (2011) · Pathology International · doi:10.1111/j.1440-1827.2011.02675.x · Cited by 30
Self-citationKimura, T., Furusato, B., Miki, J., Yamamoto, T., Hayashi, N., Takahashi, H., Kamata, Y., van Leenders, G. J. L. H., Visakorpi, T., & Egawa, S. (2012) · Pathology International · doi:10.1111/pin.12006 · Cited by 24
Self-citationMoradpour, F., & Fatemi, Z. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.6.3581 · Cited by 22
Body mass index influences prostate cancer risk at biopsy in J apanese men
Masuda, H., Kagawa, M., Kawakami, S., Numao, N., Matsuoka, Y., Yokoyama, M., Yamamoto, S., Yonese, J., Fukui, I., & Kihara, K. (2012) · International Journal of Urology · doi:10.1111/iju.12023 · Cited by 18
Ahmed, M., & Eeles, R. A. (2015) · Future Science OA · doi:10.4155/fso.15.87 · Cited by 17
Mori, M., Masumori, N., Fukuta, F., Nagata, Y., Sonoda, T., Miyanaga, N., Akaza, H., & Tsukamoto, T. (2011) · PubMed · Cited by 15
Cited by
Rebello, R. J., Oing, C., Knudsen, K. E., Loeb, S., Johnson, D. C., Reiter, R. E., Gillessen, S., Van der Kwast, T., & Bristow, R. G. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00243-0 · Cited by 1,090
Wang, L., Lu, B., He, M., Wang, Y., Wang, Z., & Du, L. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.811044 · Cited by 646
Epidemiology and Prevention of Prostate Cancer
Gandaglia, G., Leni, R., Bray, F., Fleshner, N., Freedland, S. J., Kibel, A., Stattin, P., Van Poppel, H., & La Vecchia, C. (2021) · European Urology Oncology · doi:10.1016/j.euo.2021.09.006 · Cited by 611
Inflammation-Induced Tumorigenesis and Metastasis
Hibino, S., Kawazoe, T., Kasahara, H., Itoh, S., Ishimoto, T., Sakata-Yanagimoto, M., & Taniguchi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115421 · Cited by 290
Nath, J., Paul, R., Ghosh, S. K., Paul, J., Singha, B., & Debnath, N. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118189 · Cited by 71
Metadata
- Authors
- Kimura, T., & Egawa, S.
- Venue
- International Journal of Urology
- Publisher
- Wiley
- Published
- 2018-05-08
- Volume
- 25
- Issue
- 6
- Pages
- 524-531
- ISSN
- 0919-8172 (ISSN-L)
- 1442-2042
- OpenAlex
- W2801878088
- Cited by
- 411
- References
- 55
- FWCI
- 14.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.